A recent report published by Infinium Global Research on gout
therapeutics market provides in-depth analysis of segments and sub-segments in
global as well as regional gout therapeutics market. The study also highlights
the impact of drivers, restraints and macro indicators on the global and
regional gout therapeutics market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of the global gout therapeutics market. According to the report the global gout
therapeutics market is projected to grow at a CAGR of 19.1% over the forecast
period of 2018-2024.
The report on the global gout therapeutics market covers drug class segments.
On the basis of drug class, the global gout therapeutics market is categorized
into colchicine, corticosteroids, NSAIDs and urate-lowering agents.
The report provides regional analysis covering geographies such as
North America, Europe, Asia-Pacific, and Rest of the World. In this section, the
key trends and market size for each geography are provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia,
and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe
are included in the European region. The U.S. drives the growth in the North
America region as it is the largest market in the region. The Asia-pacific the region offers a substantial potential for the market growth owing to rapid
growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x%
over the period of 2018-2024.
The report provides profiles of the companies in the global gout
therapeutics market such as Boehringer Ingelheim, GlaxoSmithKline, Alder
Biopharmaceuticals, Eli Lilly, Antares Pharma, KaloBios Pharmaceuticals,
Astellas Pharma, Can-Fite BioPharma, JW Pharmaceutical, and Ironwood
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global gout
therapeutics market. Moreover, IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of gout
therapeutics market. Moreover, the study highlights current market trends and
provides forecast from 2018-2024. We also have highlighted future trends in the
gout therapeutics market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the gout therapeutics market to
understand the present and future trends in this market and formulate their